Steris Plc (NYSE:STE)‘s stock had its “buy” rating reiterated by KeyCorp in a research report issued on Tuesday. They currently have a $91.00 price objective on the medical equipment provider’s stock. KeyCorp’s price target suggests a potential upside of 0.55% from the stock’s current price.

Other analysts have also issued reports about the company. BidaskClub lowered Steris Plc from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Zacks Investment Research upgraded Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 price objective for the company in a research report on Tuesday, July 11th. Finally, Raymond James Financial, Inc. raised their price objective on Steris Plc from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $90.75.

Shares of Steris Plc (NYSE STE) opened at 90.50 on Tuesday. The company has a market capitalization of $7.71 billion, a PE ratio of 64.74 and a beta of 1.29. Steris Plc has a one year low of $63.80 and a one year high of $91.18. The firm’s 50-day moving average price is $88.21 and its 200 day moving average price is $81.30.

Steris Plc (NYSE:STE) last announced its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, beating the Zacks’ consensus estimate of $0.80 by $0.05. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. The firm had revenue of $608.00 million for the quarter, compared to analyst estimates of $597.66 million. During the same period last year, the firm posted $0.79 earnings per share. The business’s revenue for the quarter was down 4.8% on a year-over-year basis. Analysts anticipate that Steris Plc will post $4.06 earnings per share for the current year.

WARNING: This piece of content was reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/10/19/steris-plc-ste-stock-rating-reaffirmed-by-keycorp.html.

In other Steris Plc news, Director Richard Martin Steeves sold 156,072 shares of Steris Plc stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $87.13, for a total value of $13,598,553.36. Following the completion of the sale, the director now directly owns 9,362 shares in the company, valued at $815,711.06. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of Steris Plc stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $85.69, for a total value of $856,900.00. Following the completion of the sale, the chief executive officer now owns 83,270 shares of the company’s stock, valued at $7,135,406.30. The disclosure for this sale can be found here. Insiders have sold 194,086 shares of company stock valued at $16,953,621 over the last 90 days. 2.55% of the stock is owned by corporate insiders.

A number of hedge funds have recently modified their holdings of the business. Intl Fcstone Inc. bought a new stake in Steris Plc in the second quarter worth approximately $1,482,000. GWM Advisors LLC increased its holdings in Steris Plc by 59.8% in the second quarter. GWM Advisors LLC now owns 6,741 shares of the medical equipment provider’s stock worth $553,000 after purchasing an additional 2,522 shares in the last quarter. Koch Industries Inc. bought a new stake in Steris Plc in the second quarter worth approximately $1,089,000. Westwood Holdings Group Inc. increased its holdings in Steris Plc by 25.9% in the second quarter. Westwood Holdings Group Inc. now owns 603,196 shares of the medical equipment provider’s stock worth $49,233,000 after purchasing an additional 124,155 shares in the last quarter. Finally, Ameritas Investment Partners Inc. increased its holdings in Steris Plc by 1.5% in the second quarter. Ameritas Investment Partners Inc. now owns 25,416 shares of the medical equipment provider’s stock worth $2,071,000 after purchasing an additional 379 shares in the last quarter. Institutional investors and hedge funds own 93.33% of the company’s stock.

Steris Plc Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Analyst Recommendations for Steris Plc (NYSE:STE)

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.